Showing results (401-410 of 416) with videos related to

Sort By:
Pageof 42
Journal for Immunotherapy of Cancer|March 15, 2022
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancerStephanie Lheureux, Daniela E Matei, Panagiotis A Konstantinopoulos, et al.
Nature Communications|February 16, 2024
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trialTina J Hieken, Garth D Nelson, Thomas J Flotte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2024
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic MalignanciesEleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, et al.
Nature Communications|March 14, 2025
Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trialJacob J Orme, Henan Zhang, Prashanth Lingamaneni, et al.
Cancer|November 10, 2024
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastasesDanielle K DePalo, Michelle M Dugan, Syeda Mahrukh Hussnain Naqvi, et al.
JCO Oncology Advances|April 1, 2026
Long-Term Survival in High-Grade Serous Ovarian Cancer Compared With the General US Population: A 30-Year Landmark AnalysisLuigi A De Vitis, Melissa C Larson, Hunter J Atkinson, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2022
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort studyCarl-Jacob Holmberg, Lars Ny, Tina J Hieken, et al.
Annals of Surgical Oncology|January 28, 2022
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Alzheimer'S Research & Therapy|March 28, 2024
A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factorsImogen J Swift, Rosa Rademakers, NiCole Finch, et al.
Mayo Clinic Proceedings|March 6, 2018
MyD88 and TLR4 Expression in Epithelial Ovarian CancerMatthew S Block, Robert A Vierkant, Peter F Rambau, et al.
Pageof 42